Emergency Care Research studies

Our researchers work to identify gaps between current best practices for common acute conditions that require emergency treatment. They evaluate intervention strategies intended to facilitate best practices and optimize the role of the emergency department in facilitating efficient inpatient and outpatient acute medical care.

Vaccine Effectiveness of BNT162b2 COVID-19 Vaccine Formulations among Kaiser Permanente Southern California Members

This study will evaluate Comirnaty VE. The primary objective is to estimate the VE annual BNT162b2 against SARS-CoV-2 acute respiratory infection (ARI) hospitalization in adults age> 18 years. The secondary objective is to estimate the VE of annual BNT162b2 against SARS-CoV-2 ARI emergency department (ED)/urgent care (UC) visit (without subsequent hospitalization) in adults age> 18 years.

Principal Investigator:

Sara Yee Tartof, PhD, MPH

Funding Source:

Pfizer, Inc.

Funding Years:

2025 - 2027

Vaccine Effectiveness of BNT162b2 COVID-19 Vaccine Formulations among Kaiser Permanente Southern California Members

This study will evaluate Comirnaty VE. The primary objective is to estimate the VE annual BNT162b2 against SARS-CoV-2 acute respiratory infection (ARI) hospitalization in adults age> 18 years. The secondary objective is to estimate the VE of annual BNT162b2 against SARS-CoV-2 ARI emergency department (ED)/urgent care (UC) visit (without subsequent hospitalization) in adults age> 18 years.

Principal Investigator:

Sara Yee Tartof, PhD, MPH

Funding Source:

Pfizer, Inc.

Funding Years:

2025 - 2027